AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$568M |
| 2 |
Visa
V
|
+$293M |
| 3 |
Texas Instruments
TXN
|
+$193M |
| 4 |
Intel
INTC
|
+$189M |
| 5 |
CVS Health
CVS
|
+$184M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$268M |
| 2 |
Pfizer
PFE
|
+$263M |
| 3 |
Amphenol
APH
|
+$255M |
| 4 |
Comcast
CMCSA
|
+$247M |
| 5 |
ANSS
Ansys
ANSS
|
+$236M |
Sector Composition
| 1 | Technology | 15.93% |
| 2 | Financials | 14.74% |
| 3 | Healthcare | 14.32% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Newmont
NEM
$85B
| $44.4M | 0.04% |
1,129,272
-2,345
| -0.2% | -$92.1K |
|
477
Neurocrine Biosciences
NBIX
$14B
| $44.4M | 0.04% |
876,049
-228,466
| -21% | -$11.6M |
|
478
F5
FFIV
$18.7B
| $44.2M | 0.04% |
354,525
-18,602
| -5% | -$2.32M |
|
479
Ryder
R
$7.58B
| $44M | 0.04% |
666,844
-29,451
| -4% | -$1.94M |
|
480
Carnival Corp
CCL
$42.2B
| $43.9M | 0.04% |
899,464
+118,703
| +15% | +$5.8M |
|
|
TWOU
481
DELISTED
2U, Inc.
TWOU
| $43.9M | 0.04% |
38,203
-4,943
| -11% | -$5.68M |
|
482
Ultragenyx Pharmaceutical
RARE
$3.01B
| $43.6M | 0.04% |
615,043
+236,848
| +63% | +$16.8M |
|
|
SAGE
483
DELISTED
Sage Therapeutics
SAGE
| $43.5M | 0.04% |
945,582
-108,917
| -10% | -$5.02M |
|
|
ALDR
484
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $43.5M | 0.04% |
1,327,562
-41,156
| -3% | -$1.35M |
|
485
RingCentral
RNG
$2.8B
| $43.4M | 0.04% |
1,834,900
+198,786
| +12% | +$4.7M |
|
486
Vornado Realty Trust
VNO
$7.67B
| $43.3M | 0.04% |
529,733
-17,226
| -3% | -$1.41M |
|
487
APA Corp
APA
$7.88B
| $42.9M | 0.04% |
671,226
+2,618
| +0.4% | +$167K |
|
488
Blackbaud
BLKB
$3.25B
| $42.7M | 0.04% |
643,034
+17,827
| +3% | +$1.18M |
|
489
Southwest Airlines
LUV
$16.3B
| $42.6M | 0.04% |
1,095,203
-20,419
| -2% | -$794K |
|
490
NOV
NOV
$4.77B
| $42.5M | 0.04% |
1,156,635
+467,809
| +68% | +$17.2M |
|
|
AMTD
491
DELISTED
TD Ameritrade Holding Corp
AMTD
| $42.4M | 0.04% |
1,203,943
+1,018,156
| +548% | +$35.9M |
|
|
STI
492
DELISTED
SunTrust Banks, Inc.
STI
| $42.4M | 0.04% |
967,244
-4,000
| -0.4% | -$175K |
|
493
Consolidated Edison
ED
$34.8B
| $42.1M | 0.04% |
558,978
-30,630
| -5% | -$2.31M |
|
|
PFPT
494
DELISTED
Proofpoint, Inc.
PFPT
| $41.8M | 0.04% |
559,080
-125,629
| -18% | -$9.4M |
|
495
Quest Diagnostics
DGX
$20.2B
| $41.6M | 0.04% |
491,585
+660
| +0.1% | +$55.9K |
|
496
Interpublic Group of Companies
IPG
$9.45B
| $41.4M | 0.03% |
1,851,937
-3,890,748
| -68% | -$87M |
|
|
MDCO
497
DELISTED
Medicines Co
MDCO
| $41.2M | 0.03% |
1,092,990
-4,355
| -0.4% | -$164K |
|
498
International Paper
IP
$24.7B
| $40.8M | 0.03% |
898,915
+39,947
| +5% | +$1.82M |
|
499
Nutanix
NTNX
$20.6B
| $40.7M | 0.03% |
+1,100,000
| New | +$40.7M |
|
500
Vertex Pharmaceuticals
VRTX
$100B
| $40.6M | 0.03% |
466,049
+1,358
| +0.3% | +$118K |
|